Delisting Determination, The Nasdaq Stock Market, LLC, July 10, 2023,
HTG Molecular Diagnostics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of HTG Molecular Diagnostics, Inc.
(the Company), effective at the opening of the trading session on
July 20, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b),and IM-5101-1.
The Company was notified of the Staff determination on June 6, 2023.
The Company did not appeal the Staff determination to the Hearings
Panel. The Company securities were suspended on June 15, 2023. The
Staff determination to delist the Company securities became final
on June 15, 2023.